New York, NY, Dec. 24, 2025 (GLOBE NEWSWIRE) — Betwhale has entered the US iGaming market and is being noted among new online casinos USA, drawing attention from both casino analysts and players. The platform is offering a welcome bonus of 250% up to $2,500 for casino players. Market observers report that Betwhale also provides […]

(Paris:SAN), Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025. Sanofi announced today that it has entered into an agreement to acquire Dynavax Technologies Corporation (Dynavax), a publicly traded vaccines company with a marketed adult hepatitis B vaccine (HEPLISAV-B(R)) and differentiated

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline GlobeNewswire December 24, 2025 Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025. Sanofi announced today that it has entered

New Online Casinos USA 2026 – Betwhale Enters Market with $2,500 Bonus and Speedy Cashouts GlobeNewswire December 24, 2025 New York, NY, Dec. 24, 2025 (GLOBE NEWSWIRE) — Betwhale has entered the US iGaming market and is being noted among new online casinos USA, drawing attention from both casino analysts and players. The platform is

(Paris:SAN), Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the new drug application of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) in adult patients. On December 15, 2025, Sanofi

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis GlobeNewswire December 24, 2025 Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the new drug application

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced the appointment of Gladys Wang as Vice President, Bioprocessing Commercial for Asia, Middle East and Africa (AMEA). With over twenty years of experience in life sciences and commercial leadership, Gladys will oversee Avantor's

SAN FRANCISCO, Dec. 24, 2025 (GLOBE NEWSWIRE) — gluestack by GeekyAnts secures #1 and #2 position in the Component Libraries category of the State of React Native 2025 survey. The company's flagship project, gluestack-ui, and its predecessor, NativeBase, lead the industry rankings for the current year. This performance highlights the continued adoption of the “universal”

gluestack by GeekyAnts Top Contender in Component Library Category– React Native Survey 2025 GlobeNewswire December 24, 2025 SAN FRANCISCO, Dec. 24, 2025 (GLOBE NEWSWIRE) — gluestack by GeekyAnts secures #1 and #2 position in the Component Libraries category of the State of React Native 2025 survey. The company's flagship project, gluestack-ui, and its predecessor, NativeBase,

(NASDAQ:FFAI), Faraday Future and RAK Digital Assets Oasis (also known as RAK Innovation City) have entered into a strategic non-binding MOU to collaborate across three key areas: AI, Web3 and embodied intelligence. The two parties intend to explore the joint establishment of research and innovation centers to build a forward-looking, demonstrative industrial ecosystem. FF delivered